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Peptide synthesis and characterization
Peptide synthesis of GGGK-FITC and Dabcyl-QALPETGEK-FITC was performed manually on Fmoc-Rink Amid MBHA resin (Iris Biotech GmbH) according to standard Fmoc-based solid-phase peptide synthesis (SPPS) protocols. All Fmoc-protected amino acids were coupled using 4 eq. calculated to the initial amine-loading of the resin. The coupling conditions were 4 eq. of (1-cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-carbenium hexafluorophosphate (COMU), 4 eq. of oxyma and 8 eq. of N,N-diisopropylethylamine (DIPEA) in dimethylformamide (DMF) for the first coupling reaction (20 min). For the second coupling (45 min) 4 eq. of benzotriazole-1-yl-oxy-trispyrrolidino-phosphonium hexafluorophosphate (PyBOP) and 8 eq. of DIPEA in DMF were used. Fmocdeprotection was accomplished treating the resin with a solution of 20 % piperidine in DMF for 15 min. Fluorescein isothiocyanate (FITC) was coupled using 3 eq. of its isomer and 6 eq. of DIPEA in DMF for 2 h twice. Peptide synthesis of the MLL peptide (FITC-O2Oc-GNILPSDI(Nle)DFVLKNTP-NH 2 )
was performed on Fmoc-Rink Amid TGR resin using the peptide synthesizer Syro I (Biotage). Each amino acid and the PEG moiety Fmoc-O2Oc was coupled twice using 4 eq. PyBOP and 8 eq. of DIPEA in DMF (40 min). Capping using a solution of NMP:Ac 2 O:DIPEA (10:1:1) was performed after each recoupling for 5 min. Fmoc-deprotection was performed as described above. FITC was coupled manually using 4 eq. of its isomer and 8 eq. of DIPEA in DMF for 1 h twice. Peptides were cleaved from the resin after treatment with a TFA:H 2 O:TIPS (95:2.5:2.5) solution (2x 2 h) and precipitated with Et 2 O at -20 °C. After lyophilization in a Freezone 4.5 -105 °C freeze drying system (Labconco), the peptides were dissolved in H 2 O:acetonitrile (1:1) and purified in a reversed-phase semi-preparative HPLC using a Nucleodur C18 reverse-phase column (10 x 125 mm, 110 Å, particle size 5 µm, Macherey-Nagel; solvent A: H 2 O + 0.1 % TFA; solvent B: acetonitrile + 0.1 % TFA; flow rate of 6 mL min -1
). Obtained products were lyophilized.
Peptide identity and purity were confirmed by HPLC/ESI-MS analysis performed in a HPLC-MS system (Agilent Technologies) provided with a Zorbax Eclipse, XDB-C18 reverse-phase column (4.6 x 150 mm, particle size 5 µm, Agilent; solvent A: H 2 O + 0.1 % TFA; solvent B: acetonitrile + 0.1 % TFA; flow rate of 1 mL min -1 ). The FITC labeled peptides were quantified photometrically using a V-550 UV/VIS spectrophotometer (Jasco). For GGGK-FITC and FITC labeled MLL peptides, absorbance at 494 nm was measured in a 100 mM sodium phosphate buffer (pH 8.5) and concentration calculated using the extinction coefficient ε(FITC) 494 = 77000 M -1 cm -1
. For the Dabcyl-QALPETGEK-FITC peptide, Dabcyl absorption at 494 nm was additionally taken into account (ε(Dabcyl) 494 = 14000 M -1 cm -1 ).
Protein expression and purification
A modified pET28a(+) vector coding for Staphylococcus aureus SrtA aa 60-206 was provided by AG Musacchio (Max Planck Institute, Dortmund, Germany). Variants S1 -S7 were obtained either by sequence modification using site-directed mutagenesis (Quikchange, Stratagene), restriction (NdeI
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and XhoI) and ligation or in vivo cloning each resulting in the according N-terminal His 6 -tagged protein ( Figure S3 ). These constructs were transformed into E. coli BL21-Gold (DE3) (Agilent Technologies). Transformants were used to inoculate a Luria Broth (LB) (50 μg mL -1 kanamycin) overnight pre-culture (incubated at 37 °C). This culture was used to inoculate a Terrific Broth (TB) culture (2 L) which was incubated at 37 °C until an OD 600 of 0.7 was reached. Protein expression was induced by addition of 0.5 mM IPTG and the culture was incubated overnight at 25 °C. Cells were harvested by centrifugation, resuspended in lysis buffer (50 mM Tris (pH 7.5), 150 mM NaCl, 2 mM TCEP, 10 % glycerol (v/v)) and disrupted in a microfluidizer. The cell lysate was cleared from cell debris by centrifugation (70000 rcf, 4 °C, 45 min). All subsequent purification steps were performed at 4 °C. SrtA and variants S1 -S7 were isolated from the supernatant via FPLC affinity chromatography (HisTrap Fast Flow Crude 5 mL, GE Healthcare). The column was washed with 5 CV washing buffer (50 mM Tris (pH 7.5), 150 mM NaCl, 2 mM TCEP, 5 % glycerol (v/v), 20 mM imidazole , snap frozen and stored at -80 °C.
The coding sequence for an α-Synuclein aa 1-140 (α-Syn) construct containing a C-terminal flexible linker, a SrtA recognition site as well as a His 6 -tag for affinity purification ( Figure S14 ), was synthesized and purchased from Integrated DNA Technologies. Afterwards, it was sub-cloned into a pET28a(+) vector via restriction (NcoI and XhoI) and ligation. For protein expression the vector was transformed into E. coli BL21-Gold (DE3). Transformants were used to inoculate an overnight LB preculture (50 µg mL -1 kanamycin, 37 °C). This culture was used to inoculate a kanamycin (50 µg mL -1 )
containing LB culture (2 L) which was incubated at 37 °C until an OD 600 of 0.7 was reached. Protein expression was induced by addition of 0.5 mM IPTG and performed for 4 h at 37 °C. Cells were harvested by centrifugation, resuspended in lysis buffer (50 mM Tris (pH 7.5), 150 mM NaCl) and disrupted by ultrasonication (4x 30 s cycles with 1 s on 2 s off, 40 % power, 0 °C). The cell lysate was cleared from cell debris by centrifugation (70000 rcf, 4 °C, 60 min). All follow up purification steps were performed at 4 °C. α-Syn was isolated from the supernatant via affinity chromatography (Aekta Pure, HisTrap Fast Flow Crude 5 mL, GE Healthcare). Washing was performed with lysis buffer containing 5 mM imidazole until baseline (OD 280 ) was reached. α-Syn was eluted off the column in an imidazole gradient (5 mM-500 mM). Protein containing fractions were pooled and dialyzed (Slide-A-Lyzer Dialysis Cassette, Thermo, 3.5 kDa cut-off) overnight at 4 °C against PBS buffer (pH 7.4). Resulting pure α-Syn was concentrated via ultra-filtration (Amicon, Merck, 3 kDa cut-off) up to 5 mg mL -1 and subjected to fibril formation.
The coding sequences for KIX aa 586-671 and K1 constructs ( Figure S16 ) containing Gateway attB1 and attB2 (Thermo) attachment and a PreScission protease recognition site, were synthesized and S4 purchased from Integrated DNA Technologies. Afterwards, coding regions were introduced into a pDONR201 vector (BP Clonase enzyme mix, Thermo). Subsequently, LR Clonase enzyme mix (Thermo) was utilized to introduce the coding region into a pGEX-4t-3 gateway compatible destination vector. The resulting expression vector was transformed into E. coli BL21-Gold (DE3).
Transformants were used to inoculate an overnight LB pre-culture (100 µg mL -1 ampicillin, 37 °C) and subsequently this culture was used to inoculated an ampicillin (100 µg mL -1 ) containing TB culture (2 L) which was incubated at 37 °C until an OD 600 of 1 was reached. Protein expression was induced by addition of 0.5 mM IPTG and performed overnight at 20 °C. Cells were harvested by centrifugation, resuspended in lysis buffer (50 mM Tris (pH 7.4), 500 mM NaCl, 2 mM PMSF and 2 mM DTT) and disrupted using the microfluidizer. The cell lysate was cleared from cell debris by centrifugation (70000 rcf, 4 °C, 60 min). All subsequent purification steps were performed at 4 °C. KIX and K1 were isolated from the supernatant via affinity chromatography (Aekta Pure, GSTPrep FF 16/10, GE Healthcare , snap frozen and stored at -80 °C.
All generated vector constructs were sequence proven by Sanger sequencing. All proteins where checked for their quality via SDS-PAGE.
α-Syn fibril formation and re-solubilization
For fibril formation, 4 mL of purified, soluble α-Syn (5 mg mL -1 ) were stirred at 37 °C, 1250 rpm for 4 days. The resulting suspension was ultracentrifuged (135000 rcf, 4 °C, 45 min.) in 600 µL aliquots. The protein content of the supernatant was quantified via Nanodrop (OD 280 ) to monitor the efficiency of fibril formation. After removal of the supernatant, the pellet was washed extensively with SrtA buffer (4 times 500 µL, 20 mM HEPES (pH 7.5), 150 mM NaCl, 5 mM CaCl 2 , 2 mM TCEP). For re-solubilization the fibril sample was treated either with (1 M) or without GdnHCl in SrtA buffer for 3 h at RT and gentle shaking. Supernatant was used for subsequent labeling.
α-Syn labeling reaction
Re-solubilized α-Syn fractions were diluted 1:6 with SrtA buffer (+/-1 M GdnHCl) keeping the initial GndHCl concentration and supplemented with 2 mM GGGK-FITC and either 100 µM SrtA or S7-t1.
The labeling samples were incubated for 16 h at 350 rpm and 37 °C. Samples were analyzed on a SDS-PAGE gel for fluorescence in a Gel Doc XR system (BioRad). Then the gel was coomassie stained ( Figure S15 ).
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Synthesis and characterization of bis-and triselectrophilic crosslinkers
To a solution of K 2 CO 3 (33 mmol, 3.3 eq.) in H 2 O/DCM (2:3, 18 mL) at 0 °C, the corresponding diamine (10 mmol, 1 eq.) was added. The resulting mixture was allowed to cool down before the chloroacetyl chloride (22 mmol, 2.2 eq.) was added dropwise over a 1 h period at 0 °C. After completed addition, the ice bath was removed and the mixture was allowed to stir at room temperature overnight. The desired product was extracted three times with DCM. Subsequently, the organic layer was washed with brine, dried over Na 2 SO 4 , filtrated and concentrated under reduced pressure. Product identity, was confirmed by NMR. For the triselectrophilic crosslinkers t1 and t2 the same protocol was used with adjusted equivalents. In any crosslinking reaction, freshly prepared crosslinkers must be used. 
N,N'-bis(chloroacetyl)-1,2-ethylenediamine (b1
N,N'-(oxybis(ethane-2,1-diyl))bis(2-chloroacetamide) (b4
N,N'-((ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl))bis(2-chloroacetamide) (b5
N,N'-(((oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl))bis(2-chloroacetamide) (b6
N,N',N''-(nitrilotris(propane-3,1-diyl))tris(2-chloroacetamide) (t1
N,N',N''-(nitrilotris(ethane-2,1-diyl))tris(2-chloroacetamide) (t2
Protein modification with electrophiles
The reactivity of four different electrophiles with wildtype SrtA was evaluated. Thus, 50 µM SrtA was incubated with 2 mM electrophile (acrylamide 1, 2-bromoacetamide 2, 2-chloroacetamide 3 or S6 4-maleimidobutyric acid 4) in crosslinking buffer (50 mM HEPES (pH 8.5), 150 mM NaCl, 5 mM CaCl 2 and 2 mM TCEP) at 35 °C and 350 rpm for 24 h. The reactions were analyzed by MS ( Figure S1 ).
Protein variants S1 -S6 were diluted to 50 µM in reaction buffer (50 mM HEPES (pH 8.5), 150 mM NaCl, 5 mM CaCl 2 and 2 mM TCEP) and incubated with 0.5 mM biselectrophilic crosslinkers (b1 -b6, 50 mM in DMSO) at 35 °C and 350 rpm for 24 h. To stop the reaction, solutions were concentrated by ultra-filtration (Amicon Ultra centrifugal filters, 0.5 mL, Merck, 10 kDa cut-off) and washed 5 times with SrtA buffer (20 mM HEPES (pH 7.5), 150 mM NaCl, 5 mM CaCl 2 , 2 mM TCEP) in order to remove the low molecular weight biselectrophilic crosslinkers, to exchange buffer and to concentrate final crosslinked protein variants ( Figure S4 and Figure S5 ). The resulting proteins were snap frozen and stored at -80 °C. For the crosslinking of variants S7 and K1 with the triselectrophilic crosslinkers t1
and t2, the protocol described above was applied (c t1,t2 = 1 mM, Figure 3b , S17, S18 and S20). For K1 the reaction time was shortened from to 16 h.
Measurement of apparent melting temperature (T m )
For SrtA and variants, each protein was diluted to 75 µM in 20 mM HEPES (pH 7.5), 150 mM NaCl, 5 mM CaCl 2 , 2 mM TCEP. For KIX, K1-t1 and K1-t2, a 150 µM solution in 25 mM HEPES (pH 7.4), 100 mM NaCl, 2 mM TCEP was used. Temperature was scanned (20 -95 °C) in a Prometheus NT.48
(NanoTemper Technologies) at a heating rate of 1 °C min -1 using an excitation power of 35 % for SrtA and variants and 45 % for KIX and variants. The ratio of fluorescence intensities at 350 nm and 330 nm (F 350 /F 330 ) was plotted against the temperature and apparent T m -values were determined using the Nanotemper technologies protocols (for plots and values see Figure S6 and Figure 5 ). Table S2 ).
Enzymatic hydrolysis assay
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Enzymatic transpeptidation assay
Fluorescent readout
This assay was performed analogously to the hydrolysis assay described above, but in presence of 2.5 mM triglycine (G 3 , Sigma-Aldrich). To perform the thermal activity profile of SrtA and S7-t1, transpeptidation activity was determined at various temperatures (37 °C, 45 °C, 55 °C, 60 °C, 65 °C, 70 °C, 75 °C). Triplicates were measured, averaged and plotted with error bars (1 σ). Statistical significance was evaluated by an unpaired t-test (GraphPad). We considered p-values < 0.05 as statistically significant (ns: not significant, *p < 0.05, **p < 0.01, ***p < 0.001, Figure 4b ).
HPLC-MS monitoring of transpeptidation activity
Reactions were performed at 65 °C for SrtA and S7-t1. Reaction conditions: 50 µM POI (SrtA or S7-t1); 10 µM peptidic probe (Dabcyl-QALPETGEK-FITC); 2.5 mM G 3 in SrtA buffer (20 mM HEPES (pH 7.5), 150 mM NaCl, 5 mM CaCl 2 , 2 mM TCEP); 65 °C, 12 h, 350 rpm. The reaction mixture was quenched by addition of 1 % TFA. The products of these reactions were analyzed by HPLC-MS ( Figure   4a and Figure S12 ).
Transpeptidation activity in the presence of GdnHCl
Transpeptidation activity efficiency in the presence of the denaturing agent GdnHCl was evaluated for SrtA and S7-t1. Transpeptidation activity at fixed POI (10 µM), peptidic probe (10 µM) and G 3 (2.5 mM) concentrations and at fix temperature (37 °C) was measured at several GdnHCl and plotted with error bars (1 σ). Statistical significance was evaluated by an unpaired t-test (GraphPad). We considered p-values < 0.05 as statistically significant (ns: not significant, *p < 0.05, **p < 0.01, ***p < 0.001, Figure 4c ).
Reversibility of thermal denaturation of SrtA and S7-t1
SrtA and S7-t1 were diluted to 20 µM in 20 mM HEPES (pH 7.5, 150 mM NaCl, 5 mM CaCl 2 , 2 mM TCEP and 0.01% Tween 20). These solutions were heated from r.t. to 85 °C over 30 min in a ThermoMixer (HTA-BioTec) and then cooled to r.t. over 15 min. Thereafter, transpeptidase activity was determined in analogy to the fluorescent hydrolysis assay, but in presence of 2.5 mM triglycine (G 3 , Sigma-Aldrich). Fluorescence intensity was determined after 3 h (triplicates averaged and plotted with error bars accounting for 1 σ). Statistical significance was evaluated by an unpaired t-test (GraphPad). We considered p-values > 0.05 as not significant (ns).
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HPLC-coupled High-resolution Mass spectrometry
Unmodified S7 and bicyclic S7-t1 were incubated first with 1 mM DTT then with 5.5 mM iodoacetamide, denatured in 8 M Urea and finally digested. First, LysC (Wako, Osaka, Japan) was used for 3 hours (protein-to-enzyme ratio 50:1) and after dilution with 4 volumes of 50 mM ammonium bicarbonate (AMBIC, pH 8.3) to a final concentration of 2.0 M urea, peptides were digested overnight at 37 °C with sequencing-grade modified trypsin (Promega, Madison, WI; proteinto-enzyme ratio 50:1). Peptides were desalted on C18 stage tips and 100-300 ng of peptide were separated with a PepMap100 RSLC C18 nano-HPLC column (2 m, 100 Å, 75 IDx25 cm, nanoViper, Dionex, Germany) on an UltiMate 3000 RSLCnano system (ThermoFisher Scientific, Germany) using a 65 min gradient from 5 -60% acetonitrile with 0.1% formic acid and then directly sprayed via a nanoelectrospray source (Nanospray Flex Ion Scource, Thermo Scientific) in a Q Exactive Hybrid The mass accuracy for full mass spectra was set to 20 ppm for the first and to 4.5 ppm for the second search and to 20 ppm for MS/MS spectra. Two miscleavages were allowed. A false discovery rate cut off of 1% was applied at the peptide and site decoy fraction (high-resolution MS spectra: Figure S9 , MS/MS spectrum: Figure S10 and S11).
Fluorescence Polarization Assay (FP)
Binding of K1-t1 and K1-t2 to mixed lineage leukemia transcription factor (MLL) was evaluated using MLL-derived peptide FITC-O2Oc-GNILPSDI(Nle)DFVLKNTP-NH 2 ( Figure S20) . A 40 nM solution of MLL peptide in 25 mM HEPES (pH 7.4), 100 mM NaCl and 2 mM TCEP was prepared. A 3-fold dilution of KIX, K1-t1 and K1-t2 was prepared in 14 steps in a 384-well-plate (black, round bottom, Corning) using the same buffer. 5 µL of 40 nM MLL peptide solution was then added, and the final 20 µL solution was incubated at r.t. for 1 h (final protein range of 70 µM -0 µM). Thereafter, fluorescence polarization was measured using a Spark 20M plate reader (Tecan) with λ(ex) = 485 nm and λ(em) = 525 nm. K d -values were determined by applying nonlinear regression analysis of dose-response curves (GraphPad Prism).
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Figure S1: MS spectra of SrtA after incubation with four different electrophiles: 4-maleimidobutyric acid (1), 2-bromoacetamide (2), 2-chloroacetamide (3) and acrylamide (4).
SrtA + acrylamide (4)
SrtA + 2-bromoacetamide (2) SrtA + 2-chloroacetamide (3)
SrtA + 4-maleimidobutyric acid (1) S10 Figure S2 : Chemical structure of biselectrophilic crosslinkers (b1 -b6) and their calculated lengths using 3D ChemDraw.
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Figure S3: a) Amino acid sequence of SrtA sub-cloned, expressed and evaluated in the present study; b) List of SrtA variants (highlighted in the corresponding color code, see Figure 2b ). The distance between C α atoms of the residues replaced by cysteines has been averaged over the 25 conformers of the NMR structure (PDB code: 1ija) for each variant and reported in the table.
S12 Figure S4 : SDS-PAGE gels (17 %) of protein variants (S1 -S6) before (-) and after crosslinking with biselectrophilic crosslinkers (b1 -b6). The desired crosslinked variant is indicated ( ). Figure S9 : Analysis of the modification state of the four cysteines in S7 and S7-t1 by HPLC-coupled high-resolution mass spectrometry. The spectra for the following tryptic fragments are shown: a) aa 100 -134 (including C111), b) 138 -151 (including C149), c) 176 -190 (including C177 and active site C184). Free cysteine residues or C 4 H 4 ON (grey) modified ones indicate a free cysteine in the enzyme (S7 or S7-t1) before MS workup, while C 2 H 2 O (red) modified cysteines indicate a covalent modification with t1.
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Figure S10: MS/MS spectrum of a tryptic peptide fragment aa 176 -190 from unmodified S7 harboring C177 and active site C184. Annotated MS/MS spectrum shows the corresponding b-series ions (blue) and y-series ions (red). b-and y-series ions lacking H 2 O or NH 3 are shown in orange. The following additional modification is annotated, ca: C 2 H 4 NO (modification originating from capping of free thiols during sample preparation). Table S1 : Calculated m/z-values for the ions of SrtA and the corresponding modification products ( Figure S1 ) after treatment with the electrophiles 4-maleimidobutyric acid (1), 2-bromoacetamide (2), 2-chloroacetamide (3) and acrylamide (4).
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Variant V r Variant V r SrtA 1.0 S4 0.5 S1
1.0 S4-b1 1.6 S1-b1
1.6 S4-b2 2.8 S1-b2 1.8 S4-b3 3.4 S1-b3
1.7 S4-b4 3.0 S1-b4 1.4 S4-b5 2.4 S1-b5
1.3 S4-b6 2.3 S1-b6
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